Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 1–60 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…ounded 60 bags of 19 different drugs, including 5-fluorouracil, bevacizumab, carboplatin, cisplatin, cyclophosphamide, docetaxel, doxorubic…
…mab in safety run-in cohorts, 26 patients received rhIL-15 with nivolumab plus ipilimumab. The most common cancer types were gastrointest…
…Objectives Bedaquiline (BDQ), delamanid (DLM) and pretomanid (Pa) were widely used in …
… B, Feinstein T, Shi Y, et al. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progr…
… activation in vitro, consistent with preclinical evaluation of ivonescimab. 1 In xenograft models, CR-001 demonstrated potent anti-tumor a…
…sociated with improved clinical response (p=0.0224).Conclusions PDS01ADC treatment increases peripheral NK cells with specific phenotype…
…pigenetic inhibitors (EMis). We identified inhibitors of DNMTs (guadecitabine, ‘Guad’) and HDACs (entinostat, ‘Ent’) that, when combined with…
…ric oxide at exacerbation, mean (SD) 54.67 (46.86) 59.5 (43.91) Benralizumab alone treatment, n (%) 25 (28.1) 28 (39.4) Benralizumab and pre…
…d significantly after intervention (−2.0% per quarter; p=0.02). Insulin prescribing rates did not change throughout the study period. T…
…addition of two immunosuppressive therapies, anchored on either belimumab or voclosporin.3 4 Glucocorticoids should be administered initi…
…brates/OCA (total, n = 131; 83%). At month 18, among continuous seladelpar patients, 9/15 (60%) patients with prior fibrate/OCA use achiev…